107 related articles for article (PubMed ID: 15977240)
21. [Spontaneous clearance of high risk human papillomavirus infection].
Zhang WY; Ma CB; Xiao JY; Zhou HR
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):515-8. PubMed ID: 21029604
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of abnormal cervical cytology in a sexually transmitted diseases clinic.
Kanno MB; Nguyen RH; Lee EM; Zenilman JM; Erbelding EJ
Int J STD AIDS; 2005 Aug; 16(8):549-52. PubMed ID: 16105189
[TBL] [Abstract][Full Text] [Related]
23. Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array.
de Antonio JC; Fernández-Olmos A; Mercadillo M; Lindemann ML; Mochales FB
J Virol Methods; 2008 Apr; 149(1):163-6. PubMed ID: 18328575
[TBL] [Abstract][Full Text] [Related]
24. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
[TBL] [Abstract][Full Text] [Related]
25. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
26. Colposcopy as a tool for detection of human papillomavirus infection of uterine cervix in the setting of high prevalence of gynaecologic infections.
Singh V; Parashari A; Sodhani P; Chattopadhya D; Satyanarayana L; Gupta MM; Sehgal A
Singapore Med J; 1996 Dec; 37(6):588-90. PubMed ID: 9104055
[TBL] [Abstract][Full Text] [Related]
27. The value of human papillomavirus testing in the colposcopy clinic.
Bhaumik J; Mahadevan S; Davies AE
J Obstet Gynaecol; 2004 Oct; 24(7):817-9. PubMed ID: 15763798
[TBL] [Abstract][Full Text] [Related]
28. Primary care of HPV management in HIV-infected women.
Dole PJ
Nurse Pract Forum; 2001 Dec; 12(4):214-22. PubMed ID: 11889689
[TBL] [Abstract][Full Text] [Related]
29. [Management of abnormal cervical smears: management of ASCUS cervical smears].
Benmoura D; Cravello L; Roger V; Blanc B
Contracept Fertil Sex; 1999 Mar; 27(3):178-82. PubMed ID: 10334068
[No Abstract] [Full Text] [Related]
30. [The morphological characteristics of a papillomavirus infection in the epithelial tissue of the cervix uteri in comparison with the data from the molecular biological identification of specific HPV DNA sequences].
Isakova LM; Ganina KP; Ivanova IM; Vakulenko GA
Tsitol Genet; 1998; 32(1):55-65. PubMed ID: 9695253
[TBL] [Abstract][Full Text] [Related]
31. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy.
Hopman EH; Rozendaal L; Voorhorst FJ; Walboomers JM; Kenemans P; Helmerhorst TJ
BJOG; 2000 May; 107(5):600-4. PubMed ID: 10826572
[TBL] [Abstract][Full Text] [Related]
32. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth.
Zuo Z; Goel S; Carter JE
Am J Clin Pathol; 2011 Aug; 136(2):260-5. PubMed ID: 21757599
[TBL] [Abstract][Full Text] [Related]
33. [Immunotherapy with cutaneous dinitrochlorobenzene in papillomavirus infection of the cervix uteri].
Salvo A; Rojas I; Figueroa L; Stuardo P
Rev Chil Obstet Ginecol; 1991; 56(6):460-3. PubMed ID: 1669555
[TBL] [Abstract][Full Text] [Related]
34. Trial quickly changed management of cervical abnormalities.
Zielinski SL
J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
[No Abstract] [Full Text] [Related]
35. Human Papillomavirus testing for the management of low-grade cervical abnormalities in the UK--Influence of age and testing strategy.
Cuschieri KS; Graham C; Moore C; Cubie HA
J Clin Virol; 2007 Jan; 38(1):14-8. PubMed ID: 17129758
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural modifications at uterine cervix level induced by human papillomaviruses infections.
Coman N; Ionescu MD; Mişcalencu D
Roum Arch Microbiol Immunol; 1999; 58(1):65-78. PubMed ID: 11845447
[TBL] [Abstract][Full Text] [Related]
37. [Contribution of viral typing in cytological anomalies of the cervix].
Levêque J; Classe JM; Marret H; Audrain O
J Gynecol Obstet Biol Reprod (Paris); 2005 Sep; 34(5):427-39. PubMed ID: 16142133
[TBL] [Abstract][Full Text] [Related]
38. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer.
Wang Y; Wang C; Qiao J; Wang L; Liang S
Int J Gynaecol Obstet; 2008 Apr; 101(1):21-6. PubMed ID: 18068172
[TBL] [Abstract][Full Text] [Related]
39. Costs associated with management of cervical human papillomavirus-related conditions.
Kruzikas D; Smith JS; Harley C; Buzinec P
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1469-78. PubMed ID: 22781027
[TBL] [Abstract][Full Text] [Related]
40. Expanded use of HPV test.
FDA Consum; 2003; 37(3):4. PubMed ID: 12793377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
